Anzeige
Mehr »
Lynx Broker
Login
Sonntag, 17.11.2019 Börsentäglich über 12.000 News von 617 internationalen Medien
Millionenauftrag für Microcap! Entsprechende Reaktion am Montag erwartet…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Endpoints News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
SaFTC clears Bristol-Myers' $74B deal to buy Celgene - but Dems signal a potential hard shift against Big Pharma M&A
FrNovartis scores its latest FDA OK - this time for a new sickle cell disease drug picked up in a $665M deal
FrAstraZeneca gains EU nod for diabetes triple; Amgen and Duke launch real-world PCSK9 observational study
FrFive drugs, including two Novartis therapies, win EMA endorsement
FrAtomwise's X-37 spinout gets $14.5 million to launch AI discovery efforts
FrAbbott Laboratories CEO Miles White passes baton down to successor; Lonza CEO Marc Funk hits the exit
FrUCB adds on more positive PhIII data for IL-17A/17F inhibitor bimekizumab, clearing a path to the FDA
FrEMA finalizes clinical development guideline for new gout treatments
FrRoche bags 'breakthrough' anti-fibrosis drug in $1.4B biotech buyout deal
FrNovartis spinout's first anti-aging PhIII is a flop, so now they'll turn to Parkinson's challenge as shares wilt
FrPreparing for new wave of treatments, Fujifilm drops $55 million for gene therapy center
FrAfter positive panel vote, Shionogi antibiotic scores US approval
DoUPDATED: China's BeiGene scores first-ever FDA approval - but can they carve up J&J's blockbuster franchise?
DoAmarin emerges from an expert panel review with a clear endorsement for Vascepa and high odds of success when the FDA weighs in formally
DoWhat does $62B buy you these days? A lot, says Takeda execs as the pharma player promises a blockbuster R&D future
DoShorts galore: Muddy Waters sees slide for PeptiDream, tweets concerns about FibroGen's new data
DoBioMarin breaks out positive PhII achondroplasia data; Thermo Fisher opens 'customer solutions' facility in China
DoSarepta picks up a slate of preclinical gene therapy programs, seeding new StrideBio deal with $48M upfront
DoPincer movement: California biotech gets $35M to suffocate cancer in coordinated attack
DoLittle biotech's stock flatlines as its followup attempt at a depression drug trial win ends in another defeat
DoAllergan enlists Exicure in search of hair loss drugs with $25M upfront, doubling down on area dear to AbbVie
DoAstraZeneca, Merck win red carpet treatment at the FDA as a 3-time loser seeks speedy OK for rare tumors
DoFDA panel largely opposes expanding use of Lilly, Boehringer's SGLT2 inhibitor to type 1 diabetics
DoBayer bets up to $100M on exploring new biomolecular condensate terrain with a biotech upstart
DoInvestors could emerge from Neil Woodford debacle with £1B loss, internal analysis reveals